Clinical Trial Update: Azithromycin for Meibomian Gland Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating azithromycin for meibomian gland dysfunction/dry eye was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Meibomian Gland Dysfunction
• Neuropathic Eye Pain

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Dry Eye, Neuropathic Eye Pain | Phase 4 | Status: TERMINATED | Results posted: 2025-08-06